Tan, Ronnie http://orcid.org/0000-0002-2874-9414
Murphy, Anna
Brightling, Chris
Shaw, Dominick http://orcid.org/0000-0003-4106-8469
Article History
Received: 26 March 2024
Accepted: 21 June 2024
First Online: 27 June 2024
Competing interests
: A.M. declares participation in advisory boards and honoraria for lectures from Sanofi, Chiesi, Orion and conference attendance supported by Boehringer Ingelheim. C.B. has received grants and consultancy fees from 4D Pharma, AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Mologic, Novartis, Regeneron Pharmaceuticals, Roche and Sanofi. D.S. has received speaker fees from AstraZeneca and GlaxoSmithKline, and travel fees from Sanofi. R.T. has no conflict of interests to declare.